Your browser doesn't support javascript.
loading
Development of Oxytolerant Salmonella typhimurium Using Radiation Mutation Technology (RMT) for Cancer Therapy.
Gao, Shuang; Jung, Jong-Hyun; Lin, Shun-Mei; Jang, A-Yeung; Zhi, Yong; Bum Ahn, Ki; Ji, Hyun-Jung; Hyang Lim, Jae; Guo, Huichen; Choy, Hyon E; Lim, Sangyong; Seo, Ho Seong.
Afiliação
  • Gao S; Research Division for Radiation Science, Korea Atomic Energy Research Institute, Jeongeup, Republic of Korea.
  • Jung JH; Department of Molecular Medicine (BrainKorea21 Plus), Chonnam National University Graduate School, Gwangju, Republic of Korea.
  • Lin SM; Research Division for Radiation Science, Korea Atomic Energy Research Institute, Jeongeup, Republic of Korea.
  • Jang AY; Department of Radiation Science, University of Science and Technology, Daejeon, Republic of Korea.
  • Zhi Y; Research Division for Radiation Science, Korea Atomic Energy Research Institute, Jeongeup, Republic of Korea.
  • Bum Ahn K; Department of Molecular Medicine (BrainKorea21 Plus), Chonnam National University Graduate School, Gwangju, Republic of Korea.
  • Ji HJ; Research Division for Radiation Science, Korea Atomic Energy Research Institute, Jeongeup, Republic of Korea.
  • Hyang Lim J; Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea.
  • Guo H; Research Division for Radiation Science, Korea Atomic Energy Research Institute, Jeongeup, Republic of Korea.
  • Choy HE; Department of Radiation Science, University of Science and Technology, Daejeon, Republic of Korea.
  • Lim S; Research Division for Radiation Science, Korea Atomic Energy Research Institute, Jeongeup, Republic of Korea.
  • Seo HS; Research Division for Radiation Science, Korea Atomic Energy Research Institute, Jeongeup, Republic of Korea.
Sci Rep ; 10(1): 3764, 2020 02 28.
Article em En | MEDLINE | ID: mdl-32111878
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Salmonella typhimurium / Vacinas Anticâncer / Fator 6 Ativador da Transcrição / Sistemas de Secreção Tipo III / Mutação / Proteínas de Neoplasias / Neoplasias Experimentais Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Salmonella typhimurium / Vacinas Anticâncer / Fator 6 Ativador da Transcrição / Sistemas de Secreção Tipo III / Mutação / Proteínas de Neoplasias / Neoplasias Experimentais Idioma: En Ano de publicação: 2020 Tipo de documento: Article